Business Segments · Other adjustments
Oncology & Multispecialty — Other adjustments
McKesson Oncology & Multispecialty — Other adjustments remained flat by 0.0% to -$4.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 64.7%, from -$12.75M to -$4.50M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryOther
SignalLower is better
VolatilityModerate
First reportedQ2 2024
Last reportedQ1 2026
How to read this metric
Frequent or large adjustments may indicate poor forecasting or volatile operational environments.
Detailed definition
Miscellaneous adjustments to segment financial results that do not fall into standard categories like restructuring or i...
Peer comparison
Often found in segment reconciliation tables as 'Other' or 'Miscellaneous' adjustments.
Metric ID:
mck_segment_oncology_multispecialty_other_adjustmentsHistorical Data
2 years
| FY'25 | FY'26 | |
|---|---|---|
| Value | -$51.00M | -$18.00M |
| YoY Change | — | +64.7% |
Range-$51.00M – -$18.00M
Avg YoY Growth+64.7%
Median YoY Growth+64.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — other adjustments?
- McKesson (MCK) reported oncology & multispecialty — other adjustments of -$4.50M in Q1 2026.
- How has McKesson's oncology & multispecialty — other adjustments changed year-over-year?
- McKesson's oncology & multispecialty — other adjustments increased by 64.7% year-over-year, from -$12.75M to -$4.50M.
- What does oncology & multispecialty — other adjustments mean?
- Non-standard, one-time adjustments to segment earnings.